Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

Prescription pilot just the tonic for pharmacists

Pharmacists will be able to prescribe medications and administer more vaccines under a pilot program being expanded throughout Queensland.

AAP

Draft patent amendment rules undermine pre-grant opposition

Draft patent rules threaten pre-grant opposition, a key public health safeguard. Big pharma seeks to remove essential safeguards from India’s patent laws, creating needless hurdles in pre-grant opposition. Draft rules introduce variable fees, power to determine maintainability of representation by individuals/groups. This threatens access to quality-assured, affordable generics & extends…

The Hindu

Bionano Genomics (BNGO) Challengers: 3 Biotech Innovators to Buy Instead

With the rising aging population and the emergence of new diseases, the biotech industry appears poised for steady growth. Therefore, three quality biotech stocks, Vanda Pharmaceuticals (VNDA), Organogenesis Holdings (ORGO), and Exelixis (EXEL), could be better catches than Bionano Genomics (BNGO). Read on….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Walgreens and CVS warned about selling illegal eye products

Warning letters sent to the companies claimed certain products they sell are ‘especially concerning from a public health perspective’

The Independent UK

Revolving door redux: The DEA's recently departed No. 2 returns to a Big Pharma consulting firm

Washington’s revolving door kept spinning this week as the Drug Enforcement Administration’s recently departed second-in-command returned for another stint with a high-powered consulting firm where he previously advised OxyContin maker Purdue Pharma

The Independent UK

Workplace drug testing quagmire deepens

Medical cannabis is behind an uptick in workplace drug detection and the solution isn't clear-cut, reports Andrew Bevin

Newsroom.co.nz

Xpert MTB/RIF molecular test for tuberculosis diagnosis to cost 20% less

Danaher Corporation, which sells the Xpert MTB/RIF molecular test for diagnosing tuberculosis (TB) and rifampicin resistance, has announced a lowering of the price of its standard TB test cartridge

The Hindu

Read news from The Economist, FT, and more,
with one subscription

3 Biotechs with Massive Growth Potential

These three biotech stocks have massive growth opportunities on the horizon, and could add a huge boost to any portfolio. They play in some of the most in demand markets on the planet, and have track records of finding ways to introduce products into those markets to capture big profits.…

StockNews.com

Three Scottish cities to apply for drug testing facilities, says minister

APPLICATIONS will be made for drug testing facilities in three Scottish cities, drugs policy minister Elena Whitham has said...

The National (Scotland)

Is Palatin Technologies (PTN) Stock a Biotech Buy Before Earnings?

Palatin Technologies’ (PTN) stock has plummeted more than 75% over the past year. Since its inception, the biotech company has incurred massive net losses and negative cash flows from operations. Further, it anticipates incurring additional losses in the future. So, let’s determine if PTN is a buy or sell before…

StockNews.com

Expand pharmacy capabilities to ease pressure on GPs, think tanks say

The report outlined a number of recommendations for policymakers, as well as ‘significant’ barriers facing the sector.

The Independent UK

3 Healthcare Stocks to Buy Today

The POWR Ratings system points the way to 3 of the most attractive healthcare stocks on the market today. Read on below for why you should consider adding these 3 stocks to your portfolio: Johnson & Johnson (JNJ), Amgen (AMGN) and AbbVie (ABBV).

StockNews.com

Date set for Glasgow drug consumption room crunch talks

A KEY meeting to determine how the UK’s first safe drug consumption room could be trialled in Glasgow will go ahead before the end of this month,…

The National (Scotland)

Businessline Millets Conclave: Krishna Ella calls for GST waiver for millets

The Hindu

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Which of these 3 Pharma Stocks Should You Buy, Hold or Sell?

The pharmaceutical industry is well-positioned for long-term growth thanks to rising investments in drug development and technological advancements. So, let's analyze whether Johnson & Johnson (JNJ), Calliditas Therapeutics AB (CALT), and Aurora Cannabis (ACB) are a Buy, Hold, or Sell.

The Independent UK

Big Pharma's Johnson & Johnson under investigation in South Africa over 'excessive' drug prices

U.S.-based pharmaceuticals company Johnson & Johnson is being investigated in South Africa for allegedly charging “excessive” prices for a key tuberculosis drug

The Independent UK

Free prescription discount cards from GoodRx — What’s the catch?

GoodRx’s prescription savings program offers significant discounts on prescription drugs, but not without some catches

The Independent UK

Communities across Appalachia band together for first-ever 13-state Narcan distribution event

An effort to destigmatize the use of overdose reversal drugs that started as a pilot in two West Virginia counties has expanded to all thirteen states in Appalachia this year

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu

Syngene plans to invest ₹788 cr. to expand operations in Hyderabad’s Genome Valley

Syngene to invest up to ₹788 cr in Genome Valley, Hyderabad. Expansion to create 1,000 jobs in science over 5 yrs. Inaugurated PROTAC lab & Central Compound Management facility. Ease of doing business & living in Telangana praised by Syngene's non-executive chairperson Kiran Mazumdar Shaw.

The Hindu

PM Modi to inaugurate infra projects worth ₹57,050 crore in Madhya Pradesh and Chhattisgarh

PM Modi will also lay the foundation stone for 50-bed critical care blocks in nine districts of Chhattisgarh. Read more on The Hindu

StockNews.com

3 A-Rated Pharma Stocks to Buy Today

The pharmaceutical industry is expected to grow in the upcoming years, propelled by continual advancements in medicine, aiming to meet the escalating demands for chronic disease treatment and address the needs of an aging population. Therefore, quality pharma stocks Neurocrine Biosciences (NBIX), AbbVie Inc. (ABBV), and Novo Nordisk A/S (NVO),…

StockNews.com

3 Pharma Stocks Surpassing Johnson & Johnson (JNJ)

The pharmaceutical sector is anticipated to thrive as demand grows and technology advances. While Johnson & Johnson (JNJ) receives much attention from investors, I believe Horizon Therapeutics Public Limited (HZNP), Dr. Reddy’s Laboratories (RDY), and Novartis (NVS) are better investments right now. Read on.

StockNews.com

Prescribe to Profits With These 3 Pharma Stocks

The pharma industry looks well-positioned for solid growth in the long term amid the rising incidence of chronic illnesses and technological advancements. So, quality pharma stocks, Eli Lilly and Company (LLY), Merck & Co. (MRK), and Teva Pharmaceutical (TEVA) could be profitable investments. Read on.

The Hindu

Regulator issues alert over sale of falsified versions of 2 drugs

Drugs regulator Drugs Controller General of India has directed States and Union Territories to keep vigil on sale and distribution of falsified versions of two drugs, liver medication Defitelio and Takeda’s cancer drug Adcetris after alerts from World Health Organization

The Guardian - UK

Wegovy: the slimming drug that keeps Denmark’s economy growing

Novo Nordisk, the maker of the blockbuster obesity injection, has singlehandedly saved the country from recession

1 … 45 46 47 48

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.